| Vol. 3.43 – 3 November, 2022 |
| |
|
|
| Scientists showed that kidney tubuloids could be used to model the most common inherited kidney disease, namely autosomal dominant polycystic kidney disease, reconstituting the phenotypic hallmark of this disease with cyst formation. [Nature Genetics] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators developed a clinically relevant in vivo treatment protocol mimicking the first-line five-chemotherapy treatment regimen of high-risk neuroblastoma (NB) and applied this protocol to mice with MYCN-amplified NB patient-derived xenografts (PDXs). [Science Advances] |
|
|
|
| To understand how opioids modulated brain cell type function at the single-cell level, researchers performed single nucleus RNA-seq using iPSC-derived forebrain organoids from three male opioid use disorder subjects in response to oxycodone, buprenorphine, or vehicle for seven days. [Molecular Psychiatry] |
|
|
|
|
| Researchers systematically tracked estrogen response across time at a single-cell level in multiple cell line and organoid models and developed a computational tool that quantified signaling gradients in single-cell datasets. [Nucleic Acids Research] |
|
|
|
| Investigators found that astrocytes were readily infected by SARS-CoV-2, but surprisingly, neuropilin-1, not angiotensin-converting enzyme 2, served as the principal receptor mediating cell entry. [mBio] |
|
|
|
| Scientists studied the immunological features of iPSC-retina transplantation using major histocompatibility complex (MHC)-homozygote monkey iPSC-retinas in monkeys with laser-induced retinal degeneration in MHC-matched and -mismatched transplantation. [Stem Cell Reports] |
|
|
|
| The authors used droplet-based single-cell RNA sequencing to transcriptionally profile the developing human ventral midbrain when the dopamine (DA) neurons were generated and their subsequent differentiation into functional mature DA neurons in primary fetal 3D organoid-like cultures. [Development] |
|
|
|
| To mimic the early development of the esophagus and trachea, investigators differentiated iPSCs from esophageal atresia/tracheoesophageal fistula patients, and iPSCs and ESCs from healthy individuals into mature 3D esophageal organoids. [Disease Models & Mechanisms] |
|
|
|
| Researchers analyzed the 5-fluorouracil (FU) response in patient-derived organoids that reproduced the different stages of colorectal cancer and found that 5-FU induced pyrimidine imbalance, which led to DNA damage and cell death in the actively proliferating cancer cells deficient in p53. [Communications Biology] |
|
|
|
| Scientists developed in vitro tools that allowed functional analysis of canine mammary tumors. They established the long-term culture of 24 organoid lines from 16 dogs, including organoids derived from normal mammary epithelium or benign lesions. [Scientific Reports] |
|
|
|
| Investigators reported the use of hiPSC-derived vascular organoid cells as a new cell source for the creation of an electrospun polycaprolactone-bisurea 3D-scaffold-based, perfused human macrovessel model. [Advanced Biology] |
|
|
|
| Isogenically matched cerebral organoids with and without the E200K mutation were used to investigate the propensity of E200K prion protein (PrP) to misfold following cellular insults associated with oxidative stress. [PLOS ONE] |
|
|
|
|
| The authors provide an overview of the unique features of hepatic vasculature under pathophysiological conditions and summarize the biochemical and biophysical cues that drive vasculogenesis and angiogenesis in vitro. [International Journal of Stem Cells] |
|
|
|
|
| Medera Biopharmaceutical and Novoheart, together with AstraZeneca, announced that their ongoing collaboration has led to the successful development of the world’s first human-specific in vitro, functional models of heart failure with preserved ejection fraction. [Medera Biopharmaceutical Limited (EIN Presswire)] |
|
|
|
| A new $35-million gift left to the Snyder Institute for Chronic Diseases by longstanding donor Dr. Joan Snyder will both sustain the institute in perpetuity and spark new discoveries that build on its world-leading strengths in microbiome and organoid development research. [University of Calgary] |
|
|
|
|
| February 5 – 8, 2023 Keystone, Colorado, United States |
|
|
|
|
|
| Max Delbrück Center for Molecular Medicine – Berlin, Germany |
|
|
|
| Helmholtz Munich – Munich, Germany |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| Helmholtz Munich – Oldenburg, Germany |
|
|
|
| Roger Williams Institute of Hepatology – London, England, United Kingdom |
|
|
|
|